2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase III Study of OT202 in Treating Moderate to Severe Dry Eyedry eye syndrome, eye disorder, lacrimal apparatus disorderNot yet recruitingPhase 32026-07-31NCT07740564
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular DegenerationNeovascular Age-related Macular DegenerationActive, not recruitingPhase 32025-01-07NCT05461339